The aim of this study is to explore the biological roles of fusion-negative NTRK1/2/3 overexpression in CRC, with a view to determining their potential predictive role for kinase inhibitor (including NTRKi) responses in CRC. The gene discussed is NTRK1; the disease is colorectal carcinoma.